{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:38Z","timestamp":1793237678030,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacadv.2026.103068","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:02:56Z","timestamp":1785218576000},"page":"103068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex Differences in Presentation and Outcomes of Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"5","author":[{"given":"Nicola","family":"Ciocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Fuentes Artiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annina","family":"Studer Bruengger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hugelshofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"St\u00e4mpfli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas F.","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Pieczora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annatina","family":"Suter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Pongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-6411","authenticated-orcid":false,"given":"Stefano","family":"Ministrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otmar","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Shiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hunziker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz J.","family":"Hundertmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Gr\u00e4ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jacadv.2026.103068_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103068_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.jacadv.2026.103068_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14779072.2025.2463333","article-title":"Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?","volume":"23","author":"Achten","year":"2025","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"10","key":"10.1016\/j.jacadv.2026.103068_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamacardio.2025.2948","article-title":"Transthyretin Cardiac amyloidosis in older black and Hispanic individuals with heart failure","volume":"10","author":"Ruberg","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.jacadv.2026.103068_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jacadv.2026.103068_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103068_bib7","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103068_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10741-023-10339-w","article-title":"Sex differences in transthyretin cardiac amyloidosis","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103068_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cardfail.2024.10.167","article-title":"Gender-related outcome differences in patients with transthyretin amyloidosis (attr): analysis from the National Inpatient Sample (nis)","volume":"31","author":"Seetharam","year":"2025","journal-title":"J Cardiac Failure"},{"issue":"17","key":"10.1016\/j.jacadv.2026.103068_bib10","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.3390\/jcm13175140","article-title":"Epidemiological changes in transthyretin cardiac amyloidosis: evidence from in vivo data and autoptic series","volume":"13","author":"Cianci","year":"2024","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.jacadv.2026.103068_bib11","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.57187\/s.4541","article-title":"Cardiac amyloidosis in a Swiss autopsy cohort \u2013 distribution and clinical relevance","volume":"155","author":"Baschong","year":"2025","journal-title":"Swiss Med Wkly"},{"issue":"12","key":"10.1016\/j.jacadv.2026.103068_bib12","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/ejhf.2646","article-title":"Sex differences among patients with transthyretin amyloid cardiomyopathy \u2013 from diagnosis to prognosis","volume":"24","author":"Patel","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.jacadv.2026.103068_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11897-024-00667-9","article-title":"Sex differences in transthyretin cardiac amyloidosis: unraveling the complexities in epidemiology, pathophysiology, diagnosis, and treatment","volume":"21","author":"Vilches","year":"2024","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103068_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40119-022-00265-7","article-title":"Sex differences in wild-type transthyretin amyloidosis: an analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"11","author":"Campbell","year":"2022","journal-title":"Cardiol Ther"},{"issue":"22","key":"10.1016\/j.jacadv.2026.103068_bib15","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2026.103068_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.amjms.2018.06.009","article-title":"Sex differences in heart failure with preserved ejection fraction reflected by B-type natriuretic peptide level","volume":"356","author":"Harada","year":"2018","journal-title":"Am J Med Sci"},{"issue":"Jun","key":"10.1016\/j.jacadv.2026.103068_bib17","article-title":"Integrating gender medicine into modern healthcare: progress and barriers","volume":"12","author":"Fuentes Artiles","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacadv.2026.103068_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2021.12.048","article-title":"Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis","volume":"351","author":"Zampieri","year":"2022","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103068_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/13506120701815373","article-title":"Gender-related risk of myocardial involvement in systemic amyloidosis","volume":"15","author":"Rapezzi","year":"2008","journal-title":"Amyloid"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:26:53Z","timestamp":1793237213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26004898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2772963X26004898"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103068","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Differences in Presentation and Outcomes of Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103068"}}